IndiaTickerLatest filing: Aarti Drugs Ltd - 524348 - Board Meeting Intimation for Considering The Financial Results For The Quarter Ended June 30, 2026
ObservedCompany dossier
Aarti Drugs
NSE:AARTIDRUGS · ISIN INE767A01016
- Close
- ₹411.25 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Aarti Drugs
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹556.6 Cr · PAT ₹37.1 Cr.
Exchange XBRLLatest ownership: promoter group 54.43% and public 45.57% as of 30 Jun 2026.
Exchange XBRLLatest rating action: Aarti Drugs Limited: Ratings reaffirmed
Archived reportMaterial events
Open timeline →What changed recently
Observed
Source filing Aarti Drugs Ltd - 524348 - Board Meeting Intimation for Considering The Financial Results For The Quarter Ended June 30, 2026
BSE · financial results
Observed
Source filing Action(s) taken or orders passed - Aarti Drugs Limited
NSE · exchange filing
Observed
Source filing Aarti Drugs Ltd - 524348 - Closure Directions By GPCB
BSE · exchange filing
Observed
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Aarti Drugs Limited
NSE · exchange filing
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹556.6 Cr
- Profit after tax
- ₹37.1 Cr
- EPS
- ₹4.06
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 54.43%
- Public
- 45.57%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL